209 related articles for article (PubMed ID: 36497436)
1. Gastric Cancer Risk and Pathogenesis in
Buckley KH; Niccum BA; Maxwell KN; Katona BW
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497436
[TBL] [Abstract][Full Text] [Related]
2. Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers.
Borde J; Laitman Y; Blümcke B; Niederacher D; Weber-Lassalle K; Sutter C; Rump A; Arnold N; Wang-Gohrke S; Horváth J; Gehrig A; Schmidt G; Dutrannoy V; Ramser J; Hentschel J; Meindl A; Schroeder C; Wappenschmidt B; Engel C; Kuchenbaecker K; Schmutzler RK; Friedman E; Hahnen E; Ernst C
BMC Cancer; 2022 Jun; 22(1):706. PubMed ID: 35761208
[TBL] [Abstract][Full Text] [Related]
3. Double heterozygotes of BRCA1/BRCA2 and mismatch repair gene pathogenic variants: case series and clinical implications.
Laish I; Friedman E; Levi-Reznick G; Kedar I; Katz L; Levi Z; Halpern N; Parnasa S; Abu-Shatya A; Half E; Goldberg Y
Breast Cancer Res Treat; 2021 Aug; 188(3):685-694. PubMed ID: 34086170
[TBL] [Abstract][Full Text] [Related]
4. Risk of Contralateral Breast Cancer in Women with and without Pathogenic Variants in
Hyder Z; Harkness EF; Woodward ER; Bowers NL; Pereira M; Wallace AJ; Howell SJ; Howell A; Lalloo F; Newman WG; Smith MJ; Evans DG
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32045981
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study.
Zayas-Villanueva OA; Campos-Acevedo LD; Lugo-Trampe JJ; Hernández-Barajas D; González-Guerrero JF; Noriega-Iriondo MF; Ramírez-Sánchez IA; Martínez-de-Villarreal LE
BMC Cancer; 2019 Jul; 19(1):722. PubMed ID: 31331294
[TBL] [Abstract][Full Text] [Related]
6. Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients.
Puccini A; Ponzano M; Dalmasso B; Vanni I; Gandini A; Puglisi S; Borea R; Cremante M; Bruno W; Andreotti V; Allavena E; Martelli V; Catalano F; Grassi M; Iaia ML; Pirrone C; Pastorino A; Fornarini G; Sciallero S; Ghiorzo P; Pastorino L
Cancers (Basel); 2022 Sep; 14(18):. PubMed ID: 36139606
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccination uptake and safety profile among germline BRCA1 and BRCA2 pathogenic variant carriers in Singapore.
Zhang Z; Ishak NDB; Que FVF; Chua ZY; Chan SH; Chiang J; Yie JNY
Hered Cancer Clin Pract; 2023 Apr; 21(1):5. PubMed ID: 37046302
[TBL] [Abstract][Full Text] [Related]
8. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Kwan E; Jack E; Vesprini DJ; Kuperstein G; Abrahamson JL; Fan I; Wong B; Narod SA
Am J Hum Genet; 2001 Mar; 68(3):700-10. PubMed ID: 11179017
[TBL] [Abstract][Full Text] [Related]
10. Ovarian cancer risk of Chinese women with BRCA1/2 germline pathogenic variants.
Yao L; Sun J; Hu L; Chen J; Zhang J; Xu Y; Xie Y
J Hum Genet; 2022 Nov; 67(11):639-642. PubMed ID: 35864222
[TBL] [Abstract][Full Text] [Related]
11. Li-Fraumeni syndrome: not a straightforward diagnosis anymore-the interpretation of pathogenic variants of low allele frequency and the differences between germline PVs, mosaicism, and clonal hematopoiesis.
Batalini F; Peacock EG; Stobie L; Robertson A; Garber J; Weitzel JN; Tung NM
Breast Cancer Res; 2019 Sep; 21(1):107. PubMed ID: 31533767
[TBL] [Abstract][Full Text] [Related]
12. Endometrial Cancer Risk Among Germline
Sorouri K; Lynce F; Feltmate CM; Davis MR; Muto MG; Konstantinopoulos PA; Stover EH; Kurian AW; Hill SJ; Partridge AH; Tolaney SM; Garber JE; Bychkovsky BL
JCO Precis Oncol; 2023 Sep; 7():e2300290. PubMed ID: 38061009
[TBL] [Abstract][Full Text] [Related]
13. Double PALB2 and BRCA1/BRCA2 mutation carriers are rare in breast cancer and breast-ovarian cancer syndrome families from the French Canadian founder population.
Ancot F; Arcand SL; Mes-Masson AM; Provencher DM; Tonin PN
Oncol Lett; 2015 Jun; 9(6):2787-2790. PubMed ID: 26137147
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 founder mutations do not contribute to increased risk of gastric cancer in the Polish population.
Ławniczak M; Jakubowska A; Białek A; Lubiński J; Jaworska-Bieniek K; Kaczmarek K; Starzyńska T
Hered Cancer Clin Pract; 2016; 14():3. PubMed ID: 26779294
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Italian
Figlioli G; De Nicolo A; Catucci I; Manoukian S; Peissel B; Azzollini J; Beltrami B; Bonanni B; Calvello M; Bondavalli D; Pasini B; Vignolo Lutati F; Ogliara P; Zuradelli M; Pensotti V; De Vecchi G; Volorio S; Verderio P; Pizzamiglio S; Matullo G; Aneli S; Birolo G; Zanardi F; Tondini C; Zambelli A; Livraghi L; Franchi M; Radice P; Peterlongo P
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33573335
[TBL] [Abstract][Full Text] [Related]
16. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature.
Liede A; Karlan BY; Narod SA
J Clin Oncol; 2004 Feb; 22(4):735-42. PubMed ID: 14966099
[TBL] [Abstract][Full Text] [Related]
17. Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond
Fanale D; Incorvaia L; Filorizzo C; Bono M; Fiorino A; Calò V; Brando C; Corsini LR; Barraco N; Badalamenti G; Russo A; Bazan V
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32854451
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa.
ElBiad O; Laraqui A; El Boukhrissi F; Mounjid C; Lamsisi M; Bajjou T; Elannaz H; Lahlou AI; Kouach J; Benchekroune K; Oukabli M; Chahdi H; Ennaji MM; Tanz R; Sbitti Y; Ichou M; Ennibi K; Badaoui B; Sekhsokh Y
BMC Cancer; 2022 Feb; 22(1):208. PubMed ID: 35216584
[TBL] [Abstract][Full Text] [Related]
19. High Frequency of BRCA2 c.5576_5579del Carriers in Kakogawa, Japan.
Nakamura H; Mizumoto S; Tanino H; Niwa Y; Ogino M; Sakoda Y; Tsuchiya K; Kono S; Konishi M; Ueno S; Kunihisa T
Cancer Diagn Progn; 2024; 4(3):309-314. PubMed ID: 38707742
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]